
Join to View Full Profile
32 Fruit StYawkey 7BBoston, MA 02114
Phone+1 617-724-4000
Fax+1 617-726-0453
Dr. Heist is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rebecca Heist is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital. She received her medical degree from Harvard Medical School and has been in practice 18 years. She specializes in thoracic cancer and is experienced in the treatment of lung cancer, with a special focus on clinical trials of novel agents.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2005
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
- Harvard Medical SchoolClass of 1999
Certifications & Licensure
- MA State Medical License 2001 - 2026
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2008 Apr 01
- Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2008 Apr 15
- Safety, Pharmacokinetics (PK) of AKT and MEK Combination Start of enrollment: 2010 May 04
- Join now to see all
Publications & Presentations
PubMed
- Comparative effectiveness of dupilumab versus mepolizumab and benralizumab in asthma: a multinational retrospective cohort study.Chun-Tse Hung, Yu-Chien Hung, Chi-Won Suk
The Journal of Allergy and Clinical Immunology. in Practice. 2025-04-16 - Early fungal colonization and infection as an independent predictor of in-hospital mortality in mechanically ventilated COVID-19 patients: A nationwide target trial em...Yao-Kuang Wu, Hsueh-Wen Chung, Wei-Chih Chen, Kuang-Yao Yang, Lun-Yu Jao
Journal of Infection and Public Health. 2025-04-08 - 3 citationsDatopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.Jacob Sands, Myung-Ju Ahn, Aaron Lisberg, Byoung Chul Cho, George Blumenschein Jr
Journal of Clinical Oncology. 2025-04-01
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationR S Heist, Z Piotrowska, C G Azzoli, A T Shaw, I T Lennes, L V Sequist, J F Gainor, Oxford University Press
Press Mentions
- Coronavirus Slowing Critical Cancer Research, ScreeningsDecember 21st, 2020
- Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study of AG-270, a MAT2A Inhibitor, in Patients with MTAP-Deleted TumorsOctober 27th, 2019
- Capmatinib Trial Targets New Molecular Subsets of Patients in NSCLCJuly 4th, 2016
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: